For: | Medas R, Liberal R, Macedo G. Discontinuation of antiviral therapy in chronic hepatitis B patients. World J Clin Cases 2021; 9(24): 6979-6986 [PMID: PMC8409197 DOI: 10.12998/wjcc.v9.i24.6979] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i24/6979.htm |
Number | Citing Articles |
1 |
Robert Gish, Kosh Agarwal, Anadi Mahajan, Supriya Desai, Saifuddin Kharawala, Rob Elston, Joyeta Das, Stuart Kendrick, Vera Gielen. Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review. Gastro Hep Advances 2025; 4(1): 100536 doi: 10.1016/j.gastha.2024.08.015
|
2 |
Naseem Ravanbakhsh, Andres Rivera Campana, Catherine Chapin, Ravi Jhaveri. Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format. Journal of the Pediatric Infectious Diseases Society 2024; 13(Supplement_5): S142 doi: 10.1093/jpids/piae084
|
3 |
Katerina Roma, Mark Hsu, Adam Khattak, Robert Gish. Evidence-Based Strategies for Micro-elimination of Chronic Hepatitis B Virus Infection. Current Hepatology Reports 2023; 22(3): 118 doi: 10.1007/s11901-023-00610-x
|
4 |
Nicholas Noverati, Vivian Yan, Jay W. Jun, Dina Halegoua-DeMarzio, Hie-Won Hann. The Long Game: A Functional Cure Is Possible with Nucleoside Analogues and the Tincture of Time. Livers 2023; 3(3): 325 doi: 10.3390/livers3030024
|
5 |
Verdiana Zulian, Giulia Fiscon, Paola Paci, Anna Rosa Garbuglia. Hepatitis B Virus and microRNAs: A Bioinformatics Approach. International Journal of Molecular Sciences 2023; 24(24): 17224 doi: 10.3390/ijms242417224
|
6 |
Dorien De Pooter, Wim Pierson, Soheil Pourshahian, Koen Dockx, Ben De Clerck, Isabel Najera, Heather Davis, Ellen Van Gulck, Daniel Boden. mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model. Vaccines 2024; 12(3): 237 doi: 10.3390/vaccines12030237
|